406.05
Thermo Fisher Scientific Inc 주식(TMO)의 최신 뉴스
Global Preeclampsia Diagnostics Market to Exhibit Growth at a CAGR of ~4% by 2032 | DelveInsight - GlobeNewswire Inc.
Digital PCR Market in Research By 2031 | Most Leading Companies - openPR.com
Thermo Fisher at BofA Conference: Navigating 2025 Challenges - Investing.com Australia
Transcript : Thermo Fisher Scientific Inc. Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 08 - marketscreener.com
Thermo Fisher Scientific Introduces Automated Plasmid DNA Purification Kit - Contract Pharma
Disposable Flocking Swab Market Set for Expansion | Key Players: Copan, BD, Thermo Fisher Scientific - openPR.com
PFAS Testing Market Analysis, Share, Trend, Industry Report - openPR.com
Thermo Fisher: Tariffs Hit, Valuation Compensates (NYSE:TMO) - Seeking Alpha
Virology Testing Market Expands Rapidly Amidst Global Focus - openPR.com
RoosterBio and Thermo Fisher Partner on Cell Therapies - Technology Networks
Thermo Fisher Scientific – Orion™ Pro Star series - Labmate Online
Esr Analyzer Market Detailed In New Research Report 2025 | ALCOR - openPR.com
Why Thermo Fisher Scientific Inc. (TMO) is Among the Best Medical Device Stocks to Buy Now - Insider Monkey
Hyderabad: Thermo Fisher Scientific to launch bio-incubation Supply Chain Centre - Telangana Today
Thermo Fisher Scientific Inc. (TMO): Among Billionaire Quants’ Two Sigma’s Stock Picks with Huge Upside Potential - Insider Monkey
Digital Genome Market Forecast: Growth Trends, Key Players & - openPR.com
Neuroendocrine Tumor Treatment Market: Investment Analysis & - openPR.com
Billionaire Quants’ Two Sigma’s 10 Stock Picks with Huge Upside Potential - Insider Monkey
Here's How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 20 Years - Benzinga
Thermo Fisher Scientific Inc. (TMO): Among Billionaire Mario Gabelli’s Large-Cap Stock Picks with Huge Upside Potential - Yahoo Finance
Thermo Fisher Scientific invests $2B to expand life sciences manufacturing facilities in the United States - Plant Services
Engineer III, Manufacturing Engineering (Waltham, MA, USA) - The Chemical Engineer Job Board
Thermo Fisher Scientific: 4 Reasons This Oversold Stock Is a Buy - Morningstar
Custom Antibody Market To Hit USD 1,230.09 Billion By 2032 | - openPR.com
High Content Screening Market Global Forecasts 2025-2030 - GlobeNewswire
Smarter protection: New Class II biological safety cabinet - Labmate Online
Thermo Fisher Scientific Inc. (TMO): Among Richard Chilton’s Stock Picks with Huge Upside Potential - Insider Monkey
Thermo Fisher Scientific to Present at BofA Securities 2025 Health Care Conference on May 13 - BioSpace
Thermo Fisher’s new biosafety cabinet offers improved lab safety and user experience - BioSpectrum Asia
Oversold Conditions For Thermo Fisher Scientific (TMO) - Nasdaq
Thermo Fisher Scientific Inc. stock falls Tuesday, underperforms market - MarketWatch
Benzyl Alcohol Market Scope: Growth, Share, Value, Size, - openPR.com
Global Raman Spectroscopy Market Is Booming So Rapidly - openPR.com
Immune Cell Engineering Market Generated Opportunities, - openPR.com
Laboratory Equipment Market Future Business Opportunities - openPR.com
Genome Engineering Market Generated Opportunities, Future - openPR.com
Is Thermo Fisher Scientific (TMO) One of the Best Falling Stocks to Buy According to Analysts? - Insider Monkey
Thermo Fisher Scientific to cut jobs at Orlando location - Yahoo Finance
RoosterBio Announces Collaboration with Thermo Fisher Scientific to Advance Cell & Exosome Therapy Manufacturing - PRWeb
THERMO FISHER SCIENTIFIC INC. SEC 10-Q Report - TradingView
Epigenetics Market Is Booming So Rapidly 2025-2032 -Illumina - openPR.com
Thermo Fisher Scientific Inc (TMO) Stock Analysis: A Closer Look at the 35.79% Potential Upside - DirectorsTalk Interviews
RoosterBio announces collaboration with Thermo Fisher to advance cell therapy manufacturing - BioSpectrum Asia
Thermo Fisher Scientific Leverages Integrated Solutions To Accelerate the Development of Biologic Therapeutics - Technology Networks
RoosterBio and Thermo Fisher Scientific Agree to Collaborate to Advance Cell and Exosome Therapy Manufacturing - Genetic Engineering and Biotechnology News
Lab Automation Market Set to Witness Significant Growth - openPR.com
Thermo Fisher commits $2bn to boost US operations - The Manufacturer
Thermo Fisher Scientific (NYSE:TMO) Collaborates With RoosterBio To Advance Cell Therapy Solutions - simplywall.st
Thermo Fisher reports Q1 growth, charts a steady course for 2025 - BioProcess International
Thermo Fisher Launches Improved Biological Safety Cabinet - Contract Pharma
RoosterBio Announces Collaboration with Thermo Fisher Scientific to Advance Cell and Exosome Therapy Manufacturing - PR Newswire
Research Grade Proteins Market to Witness Massive Growth by 2032 - openPR.com
자본화:
|
볼륨(24시간):